Therapeutic Effects of Colchicine in the Treatment of Symptomatic and Acute Respiratory Distress Syndrome in COVID-19 Patients

drug protocol number
5200107
drug sponsor
KACST
drug study
Colchicine
drug trial site
DCH
drug status
Completed
drug phase